Exolitus is excited to announce participation of CEO Aiste Jekabsone and BDM Kestutis Andriulaitis in the LSX Nordic Congress on October 8th–9th, 2024. Attendees are invited to visit the Exolitus showcase and meet the team to discover the groundbreaking potential of extracellular particles (EPs) as multi-targeted medicines. These innovative particles are shaping the future of healthcare by offering new solutions for precision treatments and targeted therapies.
Join Exolitus in Copenhagen to learn more about the company’s pioneering work and discover how EPs are poised to redefine the future of medicine.
For full event details, visit LSX Nordic Congress.
Secure your meeting with our team by sending us an email at info@exolitus.com